Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo

Third-party umbilical cord blood–derived regulatory T cells prevent xenogenic graft-versus-host disease

(2013) Simrit Parmar et al.   CYTOTHERAPY

Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment

(2013) Simon N. Robinson et al.   CYTOTHERAPY

Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow

(2011) A. Zarbock et al.   BLOOD

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

(2011) M. Di Ianni et al.   BLOOD

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

(2010) C. G. Brunstein et al.   BLOOD

Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD)

(2009) Tinghua Cao et al.   CELLULAR IMMUNOLOGY

Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation

(2007) M MOHTY et al.   CYTOKINE & GROWTH FACTOR REVIEWS